EC: 1.1.1.145
3beta-hydroxy-DELTA5-steroid dehydrogenase (3beta-hydroxy-DELTA5-steroid:NAD+ 3-oxidoreductase)
Pathways
| pathway id | name |
|---|---|
| BioCyc:HUMAN_PWY66-378 | androgen biosynthesis |
| BioCyc:MTBH37RV_PWY-6946 | cholesterol degradation to androstenedione II (cholesterol dehydrogenase) |
| BioCyc:MTBCDC1551_PWY-6943 | testosterone and androsterone degradation to androstendione |
| BioCyc:META_PWY-6946 | cholesterol degradation to androstenedione II (cholesterol dehydrogenase) |
| BioCyc:MTBCDC1551_PWY-6937 | superpathway of testosterone and androsterone degradation |
| BioCyc:META_PWY66-378 | androgen biosynthesis |
| BioCyc:MTBH37RV_PWY-6947 | superpathway of cholesterol degradation II (cholesterol dehydrogenase) |
| BioCyc:MTBH37RV_PWY-6945 | cholesterol degradation to androstenedione I (cholesterol oxidase) |
| BioCyc:MTBCDC1551_PWY-6947 | superpathway of cholesterol degradation II (cholesterol dehydrogenase) |
| BioCyc:MTBCDC1551_PWY-6945 | cholesterol degradation to androstenedione I (cholesterol oxidase) |
| BioCyc:HUMAN_PWY-7299 | progesterone biosynthesis |
| BioCyc:META_PWY-7299 | progesterone biosynthesis |
| BioCyc:META_PWY-6947 | superpathway of cholesterol degradation II (cholesterol dehydrogenase) |
| BioCyc:META_PWY-6945 | cholesterol degradation to androstenedione I (cholesterol oxidase) |
| BioCyc:MTBCDC1551_PWY-6946 | cholesterol degradation to androstenedione II (cholesterol dehydrogenase) |
| BioCyc:MTBCDC1551_PWY-6948 | sitosterol degradation to androstenedione |
| BioCyc:MTBCDC1551_PWY-6944 | androstenedione degradation |
| Reactome:R-BTA-1430728 | Metabolism |
| Reactome:R-BTA-556833 | Metabolism of lipids |
| Reactome:R-BTA-194002 | Glucocorticoid biosynthesis |
| Reactome:R-CFA-1430728 | Metabolism |
| Reactome:R-CFA-556833 | Metabolism of lipids |
| Reactome:R-CFA-194002 | Glucocorticoid biosynthesis |
| Reactome:R-HSA-194002 | Glucocorticoid biosynthesis |
| Reactome:R-MMU-1430728 | Metabolism |
| Reactome:R-MMU-556833 | Metabolism of lipids |
| Reactome:R-MMU-8957322 | Metabolism of steroids |
| Reactome:R-RNO-196071 | Metabolism of steroid hormones |
| Reactome:R-RNO-193048 | Androgen biosynthesis |
| Reactome:R-SSC-196071 | Metabolism of steroid hormones |
| Reactome:R-SSC-193048 | Androgen biosynthesis |
| Reactome:R-BTA-8957322 | Metabolism of steroids |
| Reactome:R-CFA-8957322 | Metabolism of steroids |
| Reactome:R-HSA-556833 | Metabolism of lipids |
| Reactome:R-MMU-196071 | Metabolism of steroid hormones |
| Reactome:R-MMU-193048 | Androgen biosynthesis |
| Reactome:R-RNO-193993 | Mineralocorticoid biosynthesis |
| Reactome:R-SSC-1430728 | Metabolism |
| Reactome:R-SSC-556833 | Metabolism of lipids |
| Reactome:R-SSC-193993 | Mineralocorticoid biosynthesis |
| Reactome:R-BTA-193993 | Mineralocorticoid biosynthesis |
| Reactome:R-CFA-193993 | Mineralocorticoid biosynthesis |
| Reactome:R-HSA-193993 | Mineralocorticoid biosynthesis |
| Reactome:R-MMU-194002 | Glucocorticoid biosynthesis |
| Reactome:R-RNO-1430728 | Metabolism |
| Reactome:R-RNO-556833 | Metabolism of lipids |
| Reactome:R-RNO-8957322 | Metabolism of steroids |
| Reactome:R-SSC-8957322 | Metabolism of steroids |
| Reactome:R-BTA-196071 | Metabolism of steroid hormones |
| Reactome:R-BTA-193048 | Androgen biosynthesis |
| Reactome:R-CFA-196071 | Metabolism of steroid hormones |
| Reactome:R-CFA-193048 | Androgen biosynthesis |
| Reactome:R-HSA-1430728 | Metabolism |
| Reactome:R-HSA-8957322 | Metabolism of steroids |
| Reactome:R-HSA-196071 | Metabolism of steroid hormones |
| Reactome:R-HSA-193048 | Androgen biosynthesis |
| Reactome:R-MMU-193993 | Mineralocorticoid biosynthesis |
| Reactome:R-RNO-194002 | Glucocorticoid biosynthesis |
| Reactome:R-SSC-194002 | Glucocorticoid biosynthesis |
| WikiPathways:WP5368 | Sulfatase and aromatase pathway |
| WikiPathways:WP5320 | Male steroid hormones in cardiomyocyte energy metabolism |
| WikiPathways:WP4524 | Alternative pathway of fetal androgen synthesis |
| PathBank:SMP0121126 | Aldosterone from Steroidogenesis |
| PathBank:SMP0000068 | Androgen and Estrogen Metabolism |
| PathBank:SMP0000373 | Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency |
| PathBank:SMP0000576 | 21-Hydroxylase Deficiency (CYP21) |
| PathBank:SMP0000718 | 3-beta-Hydroxysteroid Dehydrogenase Deficiency |
| PathBank:SMP0000356 | 17-beta Hydroxysteroid Dehydrogenase III Deficiency |
| PathBank:SMP0000575 | 11-beta-Hydroxylase Deficiency (CYP11B1) |
| PathBank:SMP0000717 | Apparent Mineralocorticoid Excess Syndrome |
| PathBank:SMP0000130 | Steroidogenesis |
| PathBank:SMP0000371 | Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH |
| PathBank:SMP0000565 | Aromatase Deficiency |
| PathBank:SMP0000577 | Corticosterone Methyl Oxidase I Deficiency (CMO I) |
| PathBank:SMP0000372 | Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency |
| PathBank:SMP0000566 | 17-alpha-Hydroxylase Deficiency (CYP17) |
| PathBank:SMP0000578 | Corticosterone Methyl Oxidase II Deficiency (CMO II) |